{"product_id":"harvard-diabetes-update-2025","title":"Harvard Diabetes Update 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: endocrinologists, primary care physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe Harvard Medical School Diabetes Update\u003c\/p\u003e\n\u003cp\u003eDiabetes Update will be held online this year, using live streaming, electronic Q\u0026amp;A, and other remote learning technologies.\u003c\/p\u003e\n\u003cp\u003eEDUCATION to MEET THE CHALLENGES of DIABETES CARE\u003c\/p\u003e\n\u003cp\u003eAt a time when our diabetes knowledge and treatment options have advanced so much, why do clinical outcomes remain suboptimal, with so many patients unable to achieve good control of their disease?\u003c\/p\u003e\n\u003ch3\u003eThe answer is rooted in four challenges:\u003c\/h3\u003e\n\u003ch3\u003eKeeping pace with rapidly advancing clinical options for diabetes care:\u003c\/h3\u003e\n\u003cp\u003eTherapies\u003c\/p\u003e\n\u003cp\u003eTechnologies\u003c\/p\u003e\n\u003cp\u003eLifestyle medicine interventions\u003c\/p\u003e\n\u003cp\u003eDesigning comprehensive therapeutic interventions based on frequent diabetes-associated diseases and complications\u003c\/p\u003e\n\u003cp\u003eAccounting for a patient’s unique biological, psychological, social, financial, educational, and cultural factors\u003c\/p\u003e\n\u003cp\u003eOvercoming structural health care barriers that require clinical strategies to fit within a particular mold\u003c\/p\u003e\n\u003cp\u003eThis course is designed to equip clinicians to meet these challenges, providing practical, evidence-based approaches to optimize care for your patients.\u003c\/p\u003e\n\u003cp\u003eSTRATEGIES, UPDATES, and BEST PRACTICES for STATE-OF-THE-ART DIABETES CARE\u003c\/p\u003e\n\u003cp\u003eThis program affords you the opportunity to learn from leaders in the field of diabetes who are distinguished for their outstanding teaching, knowledge, and innovations in clinical care.\u003c\/p\u003e\n\u003ch3\u003eParticipants can rely on this program for comprehensive education to ensure state-of-the-art treatment. Coverage includes:\u003c\/h3\u003e\n\u003cp\u003eDesigning more effective treatment plans\u003c\/p\u003e\n\u003cp\u003eCurrent anti-diabetes medications and how to use them\u003c\/p\u003e\n\u003cp\u003eDiagnosis of different types of diabetes\u003c\/p\u003e\n\u003cp\u003eUtilization of recent technology advances in diabetes care\u003c\/p\u003e\n\u003cp\u003eOptimizing care for people with obesity\u003c\/p\u003e\n\u003cp\u003eAssessing and treating cardiovascular and renal complications\u003c\/p\u003e\n\u003cp\u003eGuiding patients on physical activity and medical nutrition\u003c\/p\u003e\n\u003cp\u003eManagement of hypertension and dyslipidemia\u003c\/p\u003e\n\u003cp\u003eAddressing low engagement in therapy\u003c\/p\u003e\n\u003cp\u003eNEW DATA and PRACTICE GUIDELINES for DIABETES CARE\u003c\/p\u003e\n\u003cp\u003eThe newest data on the identification of different types of diabetes\u003c\/p\u003e\n\u003cp\u003eThe latest scientific information on how to reduce cardiovascular and renal disease risk in patients with type 2 diabetes\u003c\/p\u003e\n\u003cp\u003eNew guidelines and practice recommendations for nutrition and physical activity coupled with instruction to incorporate them into your current approaches to diabetes care\u003c\/p\u003e\n\u003cp\u003eCriteria to navigate the controversial data related to some anti-diabetes medications\u003c\/p\u003e\n\u003cp\u003eMedical vs. surgical management of obesity\u003c\/p\u003e\n\u003cp\u003eNew technologies in diabetes care: updates and implications for day-to-day care\u003c\/p\u003e\n\u003cp\u003eResearch breakthroughs\u003c\/p\u003e\n\u003cp\u003eTips and tricks for navigating barriers within health care systems\u003c\/p\u003e\n\u003cp\u003eASSESSMENT and TREATMENT of COMPLICATIONS from DIABETES\u003c\/p\u003e\n\u003ch3\u003eThe 2025 program provides education to assess and treat:\u003c\/h3\u003e\n\u003cp\u003eCardiovascular Disease\u003c\/p\u003e\n\u003cp\u003eCongestive Heart Failure\u003c\/p\u003e\n\u003cp\u003eRenal Disease\u003c\/p\u003e\n\u003cp\u003eMetabolic-Associated Steatotic Liver Disease\u003c\/p\u003e\n\u003cp\u003eOPTIMIZING HEALTH OUTCOMES for DIVERSE PATIENT POPULATIONS\u003c\/p\u003e\n\u003cp\u003eThis program also provides comprehensive guidance to account for biological, psychological, emotional, social, financial, and cultural factors that impact the development and progression of diabetes.\u003c\/p\u003e\n\u003ch3\u003eCoverage includes:\u003c\/h3\u003e\n\u003cp\u003eRacial and ethnic minorities\u003c\/p\u003e\n\u003cp\u003eThe elderly\u003c\/p\u003e\n\u003cp\u003ePeople with obesity\u003c\/p\u003e\n\u003cp\u003ePatients at high cardiovascular risk\u003c\/p\u003e\n\u003cp\u003eIndividuals with low engagement in therapy\u003c\/p\u003e\n\u003cp\u003ePatients at low socio-economic levels\u003c\/p\u003e\n\u003cp\u003eSubjects with low health literacy\/education\u003c\/p\u003e\n\u003cp\u003eIndividuals with depression\/emotional distress\u003c\/p\u003e\n\u003cp\u003ePatients with metabolic liver disease\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTuesday, April 29, 2025\u003c\/p\u003e\n\u003cp\u003e9:00am to 9:15am\u003c\/p\u003e\n\u003cp\u003eWelcome and Introduction\u003c\/p\u003e\n\u003cp\u003eCourse Directors\u003c\/p\u003e\n\u003cp\u003eIdentifying Various Types of Diabetes in Clinical Practice\u003c\/p\u003e\n\u003cp\u003e9:15am to 9:40am\u003c\/p\u003e\n\u003cp\u003eIs It Type 1 Diabetes, Type 2 Diabetes, or Something Else?\u003c\/p\u003e\n\u003cp\u003eMiriam Udler, MD, PhD\u003c\/p\u003e\n\u003cp\u003e9:40am to 10:05am\u003c\/p\u003e\n\u003cp\u003eThe Connection Between Diabetes Phenotypes and Social Determinants of Health\u003c\/p\u003e\n\u003cp\u003eJacqueline Seiglie, MD\u003c\/p\u003e\n\u003cp\u003e10:05am to 10:45am\u003c\/p\u003e\n\u003cp\u003ePanel Discussion and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eMiriam Udler, MD, PhD and Jacqueline Seiglie, MD\u003c\/p\u003e\n\u003cp\u003e10:45am to 11:00am\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eMedical Nutrition Management in Diabetes and Obesity\u003c\/p\u003e\n\u003cp\u003e11:00am to 11:25am\u003c\/p\u003e\n\u003cp\u003eDoes When You Eat Matter? Intermittent Fasting, Circadian Rhythms, and Food Order\u003c\/p\u003e\n\u003cp\u003eCourtney Peterson, PhD, MSc, MA, MS\u003c\/p\u003e\n\u003cp\u003e11:25am to 11:50am\u003c\/p\u003e\n\u003cp\u003eCurrent Dietary Recommendations in Diabetes and Obesity\u003c\/p\u003e\n\u003cp\u003eLaura Andromalos, MS, RD, RN, CSOWM, CDCES\u003c\/p\u003e\n\u003cp\u003e11:50am to 12:30pm\u003c\/p\u003e\n\u003cp\u003ePanel Discussion and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eCourtney Peterson, PhD, MSc, MA, MS and Laura Andromalos, MS, RD, RN, CSOWM, CDCES\u003c\/p\u003e\n\u003cp\u003e12:30pm to 1:20pm\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003ePrescribing Exercise to Patients with Diabetes\u003c\/p\u003e\n\u003cp\u003e1:20pm to 1:45pm\u003c\/p\u003e\n\u003cp\u003eExercise Recommendations in Type 2 Diabetes and Obesity\u003c\/p\u003e\n\u003cp\u003eEdward M. Phillips, MD\u003c\/p\u003e\n\u003cp\u003e1:45pm to 2:10pm\u003c\/p\u003e\n\u003cp\u003eA Practical Exercise Session Demonstration\u003c\/p\u003e\n\u003cp\u003eJacqueline I. Shahar, MEd, RCEP, CDCES\u003c\/p\u003e\n\u003cp\u003e2:10pm to 2:50pm\u003c\/p\u003e\n\u003cp\u003ePanel Discussion and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eEdward M. Phillips, MD and Jacqueline I. Shahar, MEd, RCEP, CDCES\u003c\/p\u003e\n\u003cp\u003e2:50pm to 3:00pm\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eSpecial Lecture\u003c\/p\u003e\n\u003cp\u003e3:00pm to 3:45pm\u003c\/p\u003e\n\u003cp\u003eImproving Diabetes Care by Addressing Patient, Health Care Professional, and Health Care System Factors\u003c\/p\u003e\n\u003cp\u003eA. Enrique Caballero, MD\u003c\/p\u003e\n\u003cp\u003eWednesday, April 30, 2025\u003c\/p\u003e\n\u003cp\u003e9:00am to 9:10am\u003c\/p\u003e\n\u003cp\u003eWelcome, Recap, and Introduction to Day 2\u003c\/p\u003e\n\u003cp\u003eCourse Directors\u003c\/p\u003e\n\u003cp\u003eObesity Management in the Patient with Diabetes\u003c\/p\u003e\n\u003cp\u003e9:10am to 9:40am\u003c\/p\u003e\n\u003cp\u003eHealth Implications of Overweight and Obesity: A Focus on Sleep Disorders\u003c\/p\u003e\n\u003cp\u003ePeminda Cabandugama, MD, DABOM\u003c\/p\u003e\n\u003cp\u003e9:40am to 10:10am\u003c\/p\u003e\n\u003cp\u003eLifestyle Modification in Obesity: Does It Work?\u003c\/p\u003e\n\u003cp\u003eJulia Lloyd, MPH, RD, CDCES\u003c\/p\u003e\n\u003cp\u003e10:10am to 10:50am\u003c\/p\u003e\n\u003cp\u003ePharmacological Management: What Intervention and When?\u003c\/p\u003e\n\u003cp\u003eW. Scott Butsch, MD, MSc\u003c\/p\u003e\n\u003cp\u003e10:50am to 11:05am\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e11:05am to 11:35am\u003c\/p\u003e\n\u003cp\u003eSurgical Management of Obesity: An Update\u003c\/p\u003e\n\u003cp\u003eMatthew M. Hutter, MD, MBA, MPH\u003c\/p\u003e\n\u003cp\u003e11:35am to 12:15pm\u003c\/p\u003e\n\u003cp\u003ePanel Discussion and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eW. Scott Butsch, MD, MSc, Matthew M. Hutter, MD, MBA, MPH, and Julia Lloyd, MPH, RD, CDCES\u003c\/p\u003e\n\u003cp\u003e12:15pm to 1:05pm\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eManagement of Traditional CV Risk Factors in Diabetes\u003c\/p\u003e\n\u003cp\u003e1:05pm to 1:45pm\u003c\/p\u003e\n\u003cp\u003eDyslipidemia Management in the Patient with Diabetes\u003c\/p\u003e\n\u003cp\u003eOm P. Ganda, MD\u003c\/p\u003e\n\u003cp\u003e1:45pm to 2:30pm\u003c\/p\u003e\n\u003cp\u003eHypertension Management in the Patient with Diabetes\u003c\/p\u003e\n\u003cp\u003eNaomi D. Fisher, MD\u003c\/p\u003e\n\u003cp\u003e2:30pm to 3:00pm\u003c\/p\u003e\n\u003cp\u003eQ and A and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eOm P. Ganda, MD and Naomi D. Fisher, MD\u003c\/p\u003e\n\u003cp\u003eSpecial Lecture\u003c\/p\u003e\n\u003cp\u003e3:00pm to 3:45pm\u003c\/p\u003e\n\u003cp\u003eMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A 2025 Vision\u003c\/p\u003e\n\u003cp\u003eKenneth Cusi, MD\u003c\/p\u003e\n\u003cp\u003eThursday, May 1, 2025\u003c\/p\u003e\n\u003cp\u003e9:00am to 9:10am\u003c\/p\u003e\n\u003cp\u003eWelcome, Recap, and Introduction to Day 3\u003c\/p\u003e\n\u003cp\u003eCourse Directors\u003c\/p\u003e\n\u003cp\u003eCardiovascular Disease in the Patient with Diabetes\u003c\/p\u003e\n\u003cp\u003e9:10am to 9:40am\u003c\/p\u003e\n\u003cp\u003eCoronary Artery Disease: Evaluation and Management\u003c\/p\u003e\n\u003cp\u003eJorge Plutzky, MD\u003c\/p\u003e\n\u003cp\u003e9:40am to 10:10am\u003c\/p\u003e\n\u003cp\u003eHeart Failure in the Patient with Diabetes: An Update\u003c\/p\u003e\n\u003cp\u003eDeepak L. Bhatt, MD, MPH, MBA\u003c\/p\u003e\n\u003cp\u003e10:10am to 10:45am\u003c\/p\u003e\n\u003cp\u003eQ and A and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eJorge Plutzky, MD and Deepak L. Bhatt, MD, MPH, MBA\u003c\/p\u003e\n\u003cp\u003e10:45am to 11:00am\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eRenal Disease in the Patient with Diabetes\u003c\/p\u003e\n\u003cp\u003e11:00am to 11:25am\u003c\/p\u003e\n\u003cp\u003eEvaluation of Chronic Kidney Disease\u003c\/p\u003e\n\u003cp\u003eKatherine R. Tuttle, MD\u003c\/p\u003e\n\u003cp\u003e11:25am to 11:50am\u003c\/p\u003e\n\u003cp\u003ePrevention and Management of Chronic Kidney Disease\u003c\/p\u003e\n\u003cp\u003eJanani Rangaswami, MD, FACP, FCRS, FAHA\u003c\/p\u003e\n\u003cp\u003e11:50am to 12:30pm\u003c\/p\u003e\n\u003cp\u003eQ and A and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eKatherine R. Tuttle, MD and Janani Rangaswami, MD, FACP, FCRS, FAHA\u003c\/p\u003e\n\u003cp\u003e12:30pm to 1:20pm\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eTechnology Advances in Diabetes Care\u003c\/p\u003e\n\u003cp\u003e1:20pm to 1:50pm\u003c\/p\u003e\n\u003cp\u003eContinuous Glucose Monitoring: A 2025 Vision\u003c\/p\u003e\n\u003cp\u003eDevin Steenkamp, MD\u003c\/p\u003e\n\u003cp\u003e1:50pm to 2:20pm\u003c\/p\u003e\n\u003cp\u003eInsulin Pumps, Closing the Loop: Where Do We Stand?\u003c\/p\u003e\n\u003cp\u003eDiana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP\u003c\/p\u003e\n\u003cp\u003e2:20pm to 2:50pm\u003c\/p\u003e\n\u003cp\u003eQ and A and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eDevin Steenkamp, MD and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP\u003c\/p\u003e\n\u003cp\u003e2:50pm to 3:00pm\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eSpecial Lecture\u003c\/p\u003e\n\u003cp\u003e3:00pm to 3:45pm\u003c\/p\u003e\n\u003cp\u003eArtificial Intelligence in Diabetes Care: Fact or Fiction?\u003c\/p\u003e\n\u003cp\u003eJames Flory, MD\u003c\/p\u003e\n\u003cp\u003eFriday, May 2, 2025\u003c\/p\u003e\n\u003cp\u003e9:00am to 9:10am\u003c\/p\u003e\n\u003cp\u003eWelcome, Recap, and Introduction to Day 4\u003c\/p\u003e\n\u003cp\u003eCourse Directors\u003c\/p\u003e\n\u003cp\u003ePharmacological Management of Type 2 Diabetes: Traditional Medications\u003c\/p\u003e\n\u003cp\u003e9:10am to 9:50am\u003c\/p\u003e\n\u003cp\u003eTraditional Medications (Biguanides, SUs, TZDs, Alpha-Glucosidase Inhibitors)\u003c\/p\u003e\n\u003cp\u003eDeborah J. Wexler, MD, MPH\u003c\/p\u003e\n\u003cp\u003e9:50am to 10:30am\u003c\/p\u003e\n\u003cp\u003eInsulin Therapy in the Patient with Diabetes\u003c\/p\u003e\n\u003cp\u003eGuillermo E. Umpierrez, MD, CDCES, FACE, MACP\u003c\/p\u003e\n\u003cp\u003e10:30am to 11:10am\u003c\/p\u003e\n\u003cp\u003eQ and A and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eDeborah J. Wexler, MD, MPH and Guillermo E. Umpierrez, MD, CDCES, FACE, MACP\u003c\/p\u003e\n\u003cp\u003e11:10am to 11:20am\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eSpecial Lecture\u003c\/p\u003e\n\u003cp\u003e11:20am to 12:00pm\u003c\/p\u003e\n\u003cp\u003eLack of Adherence to Therapy and Clinical Inertia: How to Overcome Them\u003c\/p\u003e\n\u003cp\u003eAnne Peters, MD\u003c\/p\u003e\n\u003cp\u003e12:00pm to 1:00pm\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003ePharmacological Management of Type 2 Diabetes: Newer Medications\u003c\/p\u003e\n\u003cp\u003e1:00pm to 1:35pm\u003c\/p\u003e\n\u003cp\u003eSGLT-2 Inhibitors: An Update\u003c\/p\u003e\n\u003cp\u003eSilvio E. Inzucchi, MD\u003c\/p\u003e\n\u003cp\u003e1:35pm to 2:10pm\u003c\/p\u003e\n\u003cp\u003eGLP-1 Receptor Agonists: An Update\u003c\/p\u003e\n\u003cp\u003eLee-Shing Chang, MD\u003c\/p\u003e\n\u003cp\u003e2:10pm to 2:45pm\u003c\/p\u003e\n\u003cp\u003eMineralocorticoid Receptor Antagonists: Role in Diabetes Care\u003c\/p\u003e\n\u003cp\u003eRomela Petrosyan, MD\u003c\/p\u003e\n\u003cp\u003e2:45pm to 3:30pm\u003c\/p\u003e\n\u003cp\u003eQ and A and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eSilvio E. Inzucchi, MD, Lee-Shing Chang, MD, and Romela Petrosyan, MD\u003c\/p\u003e\n\u003cp\u003e3:30pm to 3:40pm\u003c\/p\u003e\n\u003cp\u003eClosing Remarks\u003c\/p\u003e\n\u003cp\u003eCourse Directors\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405731320004,"sku":null,"price":84.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Diabetes-Update-2025.png?v=1784215445","url":"https:\/\/medicalcoursespro.com\/products\/harvard-diabetes-update-2025","provider":"Medicalcoursespro","version":"1.0","type":"link"}